Supplements for PCOS: What the Research Actually Says

If you search “PCOS supplements” online, you will find hundreds of recommendations, each claiming to be the answer to your symptoms. The reality is more nuanced. Some supplements have strong research behind them. Others have promising but preliminary evidence. And many are marketed aggressively with very little scientific support.

This guide rates each commonly discussed PCOS supplement by its actual evidence level, so you can make informed decisions with your healthcare provider.

How to read this guide

Each supplement is rated using the following evidence levels:

Guideline-endorsed means the supplement appears in at least one major international clinical guideline (ESHRE, Endocrine Society, NICE) as a recommendation. Strong trial evidence means multiple randomised controlled trials support its use in PCOS, even if it has not yet been formally included in major guidelines. Emerging evidence means some trial data exists but is limited in quantity or quality. Insufficient evidence means the supplement is commonly discussed but lacks meaningful clinical trial support for PCOS specifically.

Inositol: strong trial evidence

Inositol is the most studied supplement for PCOS. It is a naturally occurring compound involved in insulin signalling and cellular metabolism. The two forms most relevant to PCOS are myo-inositol (MI) and D-chiro-inositol (DCI).

What the research shows. Multiple randomised controlled trials have demonstrated that inositol supplementation can improve insulin sensitivity, reduce circulating androgen levels, improve ovulation rates, and support menstrual regularity in women with PCOS. A meta-analysis of studies evaluating inositol in PCOS concluded that myo-inositol is helpful in lowering testosterone levels and that effects typically require 6 months or longer to become apparent.

The ratio matters. The most studied formulation uses myo-inositol and D-chiro-inositol at a 40:1 ratio, reflecting the natural physiological plasma ratio. Research using D-chiro-inositol alone at high doses has shown potential adverse effects on oocyte quality in some trials. Dosing guidance for inositol should always specify the 40:1 MI:DCI ratio, not just the total dose. The most commonly studied dose is 4,000mg of myo-inositol per day combined with 100mg of D-chiro-inositol.

Guideline status. Inositol is endorsed by some national societies (for example, the Italian Society of Endocrinology) but is not yet included in all major international guidelines such as ESHRE or the Endocrine Society. Evidence quality is strong, but formal guideline inclusion requires a specific consensus process that has not yet occurred for all bodies.

Discuss with your doctor before starting.

Vitamin D: guideline-endorsed (when deficient)

Vitamin D deficiency is common in the general population and particularly prevalent in women with PCOS. Research has linked low vitamin D levels in PCOS to worse insulin sensitivity, higher androgen levels, and lower mood.

What the research shows. Supplementation in women who are deficient has been shown to improve menstrual regularity (after approximately 3 months), and may improve insulin sensitivity and mood. Routine high-dose supplementation without confirmed deficiency is not supported by current guidelines.

The key point: get tested first. If your 25-OH vitamin D level is below the normal range (typically below 30 ng/mL or 75 nmol/L), supplementation is clearly appropriate. If your levels are normal, supplementation is unlikely to provide additional benefit for PCOS specifically.

Guideline status. Supplementation when deficient is guideline-endorsed. Routine supplementation regardless of status is not.

Omega-3 fatty acids: emerging evidence

Omega-3 fatty acids (EPA and DHA, primarily from fish oil) have anti-inflammatory properties and have been studied in PCOS for their effects on metabolic markers.

What the research shows. Randomised controlled trial data shows modest improvements in triglyceride levels and some androgen markers. The effects on insulin resistance and menstrual regularity are less consistent across studies.

Guideline status. Not guideline-endorsed for PCOS specifically. Evidence is emerging but not yet strong enough for formal recommendation.

NAC (N-acetylcysteine): emerging evidence

NAC is an antioxidant that has been studied as a potential alternative or adjunct to metformin in PCOS.

What the research shows. Some trial data suggests NAC may improve insulin sensitivity, reduce androgen levels, and support ovulation in PCOS. A few studies have shown effects comparable to metformin on certain markers. However, the total body of evidence is smaller and less consistent than for inositol or metformin.

Guideline status. Not guideline-endorsed. Evidence is promising but insufficient for formal recommendation.

Magnesium: insufficient evidence for PCOS specifically

Magnesium is involved in hundreds of enzymatic processes including glucose metabolism and insulin signalling. Deficiency is common in the general population.

What the research shows. While magnesium supplementation has general health benefits and may support sleep quality and stress reduction, there is insufficient clinical trial evidence to recommend it specifically for PCOS. Some small studies suggest improvements in insulin resistance markers, but the data is not robust enough to draw firm conclusions.

Guideline status. Not guideline-endorsed for PCOS. May be reasonable as part of general health support, particularly if dietary intake is low.

Zinc: insufficient evidence for PCOS specifically

Zinc plays a role in immune function, hormone metabolism, and skin health.

What the research shows. A few small studies in PCOS populations have shown improvements in hirsutism and hair loss markers with zinc supplementation. Evidence is preliminary and inconsistent.

Guideline status. Not guideline-endorsed for PCOS.

Chromium: insufficient evidence

Chromium is marketed for blood sugar management and is sometimes recommended for PCOS.

What the research shows. A small number of studies suggest modest effects on fasting glucose and insulin in PCOS, but the evidence is limited and inconsistent. Major guidelines do not recommend chromium for PCOS.

Guideline status. Not guideline-endorsed.

Berberine: emerging evidence

Berberine is a plant compound studied for its effects on blood sugar and insulin sensitivity, sometimes compared to metformin.

What the research shows. A limited number of trials in PCOS populations suggest berberine may improve insulin resistance and reduce androgen levels. Some studies report effects comparable to metformin, but the evidence base is much smaller. Quality and consistency of available studies vary.

Guideline status. Not guideline-endorsed. If you are considering berberine, discuss it with your doctor, particularly if you are also taking metformin or other medications.

Practical takeaways

Start with testing. Before adding supplements, know your baseline: fasting insulin, glucose, HbA1c, vitamin D, and androgen levels. This tells you what actually needs addressing.

Prioritise what has evidence. Inositol (40:1 ratio) and vitamin D (if deficient) have the strongest evidence for PCOS specifically. Everything else is further down the evidence ladder.

Supplements are not replacements. No supplement replaces the fundamentals of PCOS management: nutrition, movement, sleep, stress management, and appropriate medical treatment. Supplements work best as additions to an existing foundation.

Discuss with your doctor. Particularly if you are taking medications (metformin, hormonal contraceptives, spironolactone), as interactions are possible.

Track what you take and how you feel. If you start a supplement, log it alongside your symptoms so you can assess whether it is making a difference over time.

This content is for informational purposes only. Always consult your healthcare provider before starting supplements, particularly if you are taking medications.